IPC
LAB icon

Independent Portfolio Consultants’s Standard BioTools LAB Stock Holding History

Independent Portfolio Consultants’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-60
Closed -$3K – 958
2015
Q1 		$3K Hold
60
– – ﹤0.01% 810
2014
Q4 		$2K Buy
+60
New +$1.7K ﹤0.01% 766

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Independent Portfolio Consultants's LAB Position: Q2 2015 in Review

Independent Portfolio Consultants sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 60 shares — an estimated $3K sold.

Independent Portfolio Consultants first reported a position in LAB in Q4 2014 and held it in 2 quarters. The position peaked at $3K in Q1 2015. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • Independent Portfolio Consultants reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 60 Standard BioTools shares in Q2 2015, an estimated $3K.
  • Independent Portfolio Consultants first reported a position in Standard BioTools in Q4 2014 and held it in 2 quarters.
  • Independent Portfolio Consultants's Standard BioTools position peaked at $3K in Q1 2015.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on Independent Portfolio Consultants's 13F filing for Q2 2015, filed 27 Jul 2015.